Artelo Biosciences (ARTL) Depreciation & Amortization (CF) (2017 - 2021)
Artelo Biosciences (ARTL) posted quarterly Depreciation & Amortization (CF) of $61.0 for Q2 2021, down 50.81% year-over-year from $124.0 in Q2 2020, and down 1.61% quarter-over-quarter from $62.0 in Q1 2021.
Artelo Biosciences (ARTL) Depreciation & Amortization (CF) (2017 - 2021) Analysis & Trends
Artelo Biosciences (ARTL) has reported Depreciation & Amortization (CF) for 5 consecutive years, with $61.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Depreciation & Amortization (CF) fell 50.81% year-over-year to $61.0; the TTM figure through Mar 2022 stood at $61.0 (changed N/A YoY), while the FY2020 annual figure was $500.0, down 1.96% from the prior year.
- Depreciation & Amortization (CF) retreated to $61.0 in Q2 2021 per ARTL's latest filing, from $62.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $243.0 in Q2 2019 and bottomed at $33.0 in Q3 2018.
- Historically, Depreciation & Amortization (CF) has averaged $96.33 across 5 years, with a median of $73.0 in 2018.
- Annual changes were most pronounced in 2019 — Depreciation & Amortization (CF) jumped 284.85% — and 2020, when it plunged 51.61%.
- Artelo Biosciences' Depreciation & Amortization (CF) stood at $72.0 in 2017, then dropped by 2.78% to $70.0 in 2018, then soared by 77.14% to $124.0 in 2019, then slumped by 51.61% to $60.0 in 2020, then advanced by 1.67% to $61.0 in 2021.
- Business Quant data shows ARTL's Depreciation & Amortization (CF) at $61.0 in Q2 2021, $62.0 in Q1 2021, and $60.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2021 | 61.00 |
| May 31, 2021 | 61.00 |
| Feb 28, 2021 | 62.00 |
| Feb 28, 2021 | 62.00 |
| Nov 30, 2020 | 60.00 |
| Nov 30, 2020 | 60.00 |
| Aug 31, 2020 | 128.00 |
| Aug 31, 2020 | 128.00 |
| May 31, 2020 | 124.00 |
| May 31, 2020 | 124.00 |
| Feb 29, 2020 | 124.00 |
| Feb 29, 2020 | 124.00 |
| Nov 30, 2019 | 124.00 |
| Nov 30, 2019 | 124.00 |
| Aug 31, 2019 | 127.00 |
| Aug 31, 2019 | 127.00 |
| May 31, 2019 | 243.00 |
| May 31, 2019 | 243.00 |
| Feb 28, 2019 | 70.00 |
| Feb 28, 2019 | 70.00 |